Results 281 to 290 of about 129,945 (312)

Psoriasis – Januskinase-Inhibitor als neue Therapieoption?

Aktuelle Dermatologie, 2016
openaire   +1 more source

Aktualisierte AD-Leitlinie: JAK-Inhibitor als Erstlinientherapie empfohlen

hautnah dermatologie, 2023
openaire   +1 more source

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

mUC: PD-1-Inhibitor als neue Option

Im Focus Onkologie, 2017
openaire   +1 more source

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Phenol als Inhibitor der Huminbildung bei der Proteinhydrolyse

Angewandte Chemie, 1963
F. Drawert, K.‐H. Reuther
openaire   +1 more source

PD-1-Inhibitor auch als Erstlinientherapie gut wirksam

Der Deutsche Dermatologe, 2017
Reimund Freye, null red
openaire   +1 more source